This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Certainly! Here's the article for you:
Title: *Unveiling the Innovations of Anthony Tomlinson from South San Francisco*
Introduction:
Anthony Tomlinson, an inventive mind based in South San Francisco, CA, has been making waves in the world of liquid protein formulations. With a total of two patents under his belt, Tomlinson's contributions to the field of polypeptides and surfactants are commendable.
Latest Patents:
1. *Composition and methods for stabilizing liquid protein formulations*: In his recent patent, Tomlinson introduces liquid formulations that consist of polypeptides and surfactants, with a unique composition featuring isosorbide polyoxyethylene (POE) fatty acid esters. These formulations not only stabilize the proteins but also offer novel methods of treatment for patients.
2. *Polysorbate mixtures having modified fatty acid ester distribution*: Tomlinson's patent showcases polysorbate 20 compositions that exhibit specific fatty acid ester concentrations, particularly beneficial in pharmaceutical formulations for enhancing stability.
Career Highlights:
Anthony Tomlinson is a valued member of Genentech, Inc., a prominent biotechnology company recognized for its groundbreaking advancements in the healthcare industry. His dedication to innovation and precision has significantly contributed to the company's success in developing cutting-edge solutions.
Collaborations:
Within the dynamic environment of Genentech, Tomlinson collaborates with accomplished professionals like Sandeep Yadav and Nidhi Doshi. Together, they synergize their expertise to drive forward-thinking research and development initiatives in the realm of liquid formulations.
Conclusion:
In conclusion, Anthony Tomlinson stands as a beacon of innovation, constantly pushing the boundaries of scientific discovery in the realm of liquid protein formulations. His inventive spirit and collaborative efforts at Genentech, Inc. underscore his commitment to revolutionizing the field and positively impacting patient care worldwide.
If you have any more requests or need further information, feel free to ask!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
